ROBIN BARBOUR

Anti-Abeta Antibodies

#2 | 2025-09-11

US20250282838A1

Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease

#3 | 2025-06-12

US20250186567A1

MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE

#4 | 2025-06-05

US20250179161A1

Anti-Abeta Antibodies

#5 | 2024-10-17

US20240343769A1

Multi-epitope vaccine for the treatment of Alzheimer's disease

#6 | 2024-09-19

US20240309078A1

ANTIBODIES RECOGNIZING TAU

#7 | 2024-06-27

US20240209073A1

ANTIBODIES RECOGNIZING TAU

#8 | 2023-11-16

US20230364210A1

ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE

#9 | 2023-11-09

US20230355756A1

ALPHA-SYNUCLEIN VACCINE FOR THE TREATMENT OF SYNUCLEINOPATHIES

#10 | 2023-11-09

US20230355729A1

MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE

#11 | 2023-10-26

US20230340094A1

Tau Immunotherapy

#12 | 2023-10-19

US20230331828A1

Anti-Abeta Antibodies

#13 | 2023-10-12

US20230322876A1

Multi-epitope vaccine for the treatment of Alzheimer's disease

#14 | 2023-10-05

US20230312662A1

Multi-epitope vaccine for the treatment of Alzheimer's disease

#15 | 2023-09-28

US20230302127A1

TAU VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE

#16 | 2023-09-21

US20230295254A1

Multi-epitope vaccine for the treatment of Alzheimer's disease

#17 | 2023-08-10

US20230250161A1

ANTIBODIES RECOGNIZING TAU

#18 | 2023-07-20

US20230228772A1

Methods For Detecting Phosphorylated Alpha-Synuclein

#19 | 2023-06-15

US20230183304A1

Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease

#20 | 2023-04-27

US20230126858A1

Tau immunotherapy

#21 | 2022-11-24

US20220372118A1

ANTIBODIES RECOGNIZING TAU

#22 | 2022-09-01

US20220275067A1

ANTIBODIES RECOGNIZING TAU

#23 | 2022-08-04

US20220242940A1

Anti-abeta antibodies

#24 | 2022-05-19

US20220153821A1

ANTIBODIES RECOGNIZING TAU

#25 | 2022-03-24

US20220089762A1

Anti-Abeta Antibodies

#26 | 2022-03-24

US20220089702A1

Antibodies recognizing tau

#27 | 2022-02-17

US20220049009A1

Anti-Abeta Antibodies

#28 | 2022-02-10

US20220041701A1

Anti-Abeta antibodies

#29 | 2022-02-10

US20220041700A1

Anti-Abeta antibodies

#30 | 2022-02-10

US20220041699A1

Anti-abeta antibodies

#31 | 2021-08-26

US20210261652A1

Antibodies recognizing tau

#32 | 2021-06-03

US20210165000A1

Methods For Detecting Phosphorylated Alpha-Synuclein

#33 | 2021-05-06

US20210130449A1

Antibodies recognizing tau

#34 | 2021-02-04

US20210032319A1

Tau immunotherapy

#35 | 2021-01-21

US20210017278A1

Treatment and Prophylaxis of Amyloidosis

#36 | 2020-11-26

US20200369755A1

Antibodies recognizing tau

#37 | 2020-10-22

US20200331992A1

Anti-transthyretin antibodies

#38 | 2020-10-08

US20200317763A1

Antibodies recognizing alpha-synuclein

#39 | 2020-09-24

US20200299397A1

Blood-Brain Barrier Shuttles Containing Antibodies Recognizing Alpha-Synuclein

#40 | 2020-08-06

US20200249244A1

Methods of detecting transthyretin

#41 | 2020-04-23

US20200123239A1

Tau immunotherapy

#42 | 2019-10-31

US20190330316A1

Antibodies recognizing tau

#43 | 2019-10-31

US20190330314A1

Antibodies recognizing tau

#44 | 2019-10-24

US20190322728A1

Tau immunotherapy

#45 | 2019-10-17

US20190315843A1

Antibodies recognizing α-synuclein

#46 | 2019-09-12

US20190277863A1

Infrared assay detecting secondary structure profiles of alpha-synuclein

#47 | 2019-07-25

US20190227082A1

ASSAY FOR DETECTING TOTAL AND S129 PHOSPHORYLATED ALPHA-SYNUCLEIN

#48 | 2019-02-28

US20190062415A1

Antibodies recognizing alpha-synuclein

#49 | 2018-12-27

US20180371067A1

Anti-laminin4 antibodies specific for LG4-5

#50 | 2018-08-23

US20180237516A1

ANTIBODIES THAT RECOGNIZE IAPP

#51 | 2018-07-26

US20180208646A1

Anti-Laminin4 antibodies specific for LG4-5

#52 | 2018-06-21

US20180171011A1

ANTIBODIES THAT RECOGNIZE IAPP

#53 | 2017-07-06

US20170192017A1

Methods for detecting phosphorylated alpha-synuclein

#54 | 2017-06-22

US20170174777A1

Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein

#55 | 2017-06-08

US20170158755A1

ANTI-LAMININ4 ANTIBODIES SPECIFIC FOR LG1-3

#56 | 2017-06-01

US20170152310A1

Antibodies recognizing α-synuclein

#57 | 2016-02-04

US20160031976A1

Tau immunotherapy

#58 | 2015-09-17

US20150259408A1

Anti-Laminin4 antibodies specific for LG4-5

#59 | 2015-09-17

US20150259404A1

ANTIBODIES RECOGNIZING ALPHA-SYNUCLEIN

#60 | 2015-07-09

US20150191541A1

ANTIBODIES THAT RECOGNIZE IAPP

#61 | 2015-04-23

US20150110777A1

Antibodies that recognize IAPP

#62 | 2015-04-23

US20150110776A1

Antibodies that recognize IAPP

#63 | 2014-11-27

US20140348843A1

APOE IMMUNOTHERAPY

#64 | 2014-07-03

US20140186371A1

COMPOSITIONS AND METHODS FOR TREATING DISEASES OF PROTEIN AGGREGATION INVOLVING IC3B DEPOSITION

#65 | 2014-05-08

US20140127225A1

COMPOSITIONS AND METHODS FOR TREATING DISEASES OF PROTEIN AGGREGATION INVOLVING IC3B DEPOSITION

#66 | 2014-05-08

US20140127131A1

Antibodies recognizing alpha-synuclein

#67 | 2014-02-20

US20140050733A1

APOE IMMUNOTHERAPY

#68 | 2013-11-28

US20130317199A1

Antibodies to alpha-synuclein

#69 | 2012-10-11

US20120258041A1

COMPOSITIONS AND METHODS FOR TREATING DISEASES OF PROTEIN AGGREGATION INVOLVING IC3B DEPOSITION

#70 | 2012-08-09

US20120204275A1

APOE immunotherapy

#71 | 2010-08-12

US20100203631A1

Antibodies to alpha-synuclein

#72 | 2005-09-08

US20050196818A1